Adjuvant therapy use among Appalachian breast cancer survivors
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference32 articles.
1. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years adjuvant treatment for breast cancer.;Howell;Lancet,2005
2. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.;Forbes;Lancet Oncol,2008
3. A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer.;Coombes;N Engl J Med,2004
4. A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.;Goss;N Engl J Med,2003
5. Adherence and discontinuation of oral hormonal therapy in patients with hormone receptor positive breast cancer.;Ayres;Int J Clin Pharm,2014
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Survival benefits associated with being adherent and having longer persistence to adjuvant hormone therapy across up to five years among U.S. Medicare population with breast cancer;Breast Cancer Research and Treatment;2023-06-16
2. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review;The Breast;2022-08
3. Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred;Scientific Reports;2022-05-16
4. Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer;Cancer Treatment Reviews;2021-11
5. Examining factors associated with adherence to hormonal therapy in breast cancer patients;Research in Social and Administrative Pharmacy;2020-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3